Renjith Seela Bhadran | Medicine and Health Sciences | Best Academic Researcher Award

Published on by Research Awards

Best Academic Researcher Award

Renjith Seela Bhadran
ResearcherRenjith Seela Bhadran
AffiliationAmrita Vishwa Vidyapeetham
CountryIndia
Google Scholar IDCacLWwwAAAAJ&hl
Documents8
Citations3
h-index1
Subject AreaMedicine and Health Sciences
EventInternational Research Awards

Renjith Seela Bhadran is affiliated with Amrita Vishwa Vidyapeetham, India, and is associated with research activities within the broad domain of Medicine and Health Sciences. Academic recognition programs such as the Best Academic Researcher Award acknowledge researchers who contribute to scholarly advancement through publications, scientific inquiry, academic collaboration, and knowledge dissemination. Evaluation commonly considers publication output, citation metrics, research quality, and disciplinary impact.[1][2]

Based on publicly available scholarly indicators, the researcher maintains an academic profile with indexed publications and citation activity. Such metrics provide a quantitative overview of scholarly visibility while complementing qualitative assessments of scientific contribution, innovation, and academic engagement.[1][3]

Abstract

This article presents an academic recognition profile of Renjith Seela Bhadran in relation to consideration for the Best Academic Researcher Award at the International Research Awards. The profile summarizes scholarly indicators, institutional affiliation, research engagement, publication activity, and broader academic contributions within Medicine and Health Sciences. The evaluation framework emphasizes research productivity, citation visibility, knowledge dissemination, and participation in scholarly advancement through peer-reviewed academic work.[1][4]

Keywords

  • Academic Research
  • Medicine and Health Sciences
  • Research Evaluation
  • Scholarly Publications
  • Citation Analysis
  • Research Impact
  • Academic Recognition
  • International Research Awards

Introduction

Academic awards serve an important role in recognizing contributions that advance scientific understanding, strengthen research communities, and encourage continued scholarly excellence. Within medicine and health sciences, researchers contribute to evidence generation, healthcare innovation, translational applications, and scientific education. Award evaluations typically incorporate publication records, citation metrics, institutional affiliations, and demonstrated research engagement as part of a comprehensive assessment process.[3][4]

Research Profile

Renjith Seela Bhadran is associated with Amrita Vishwa Vidyapeetham, a multidisciplinary higher education institution in India that supports research and innovation across numerous scientific domains. Publicly available scholarly indicators show a Google Scholar profile reflecting publication activity and citation accumulation. Such indicators are commonly used to assess academic visibility and the dissemination of research findings within scholarly networks.[2][3]

Research Contributions

Research contributions in medicine and health sciences encompass scientific investigations that improve understanding of human health, disease mechanisms, healthcare delivery, diagnostics, therapeutics, public health interventions, and clinical outcomes. Academic contributions are often reflected through peer-reviewed publications, collaborative projects, conference presentations, and dissemination of evidence-based findings.[4]

  • Participation in scholarly publication and dissemination activities.
  • Contribution to academic and scientific knowledge development.
  • Engagement with research methodologies relevant to health sciences.
  • Support for evidence-based academic inquiry and scientific communication.

Publications

Publication output remains one of the principal indicators of academic productivity. Indexed publications contribute to scientific discourse by presenting new findings, methodological developments, reviews, and applied research outcomes. The researcher’s documented publication record demonstrates participation in scholarly communication and supports visibility within relevant academic communities.[1]

  1. Peer-reviewed journal publications indexed through academic databases.
  2. Research outputs contributing to medicine and health sciences literature.
  3. Scholarly works accessible through researcher profile platforms.

Research Impact

Research impact may be evaluated through citation counts, scholarly engagement, publication reach, and contribution to future investigations. Citation metrics provide evidence that published work has been referenced by other researchers and incorporated into subsequent academic discussions. While quantitative indicators do not fully capture scientific significance, they contribute to a broader understanding of research influence and scholarly visibility.[1][3]

Award Suitability

The Best Academic Researcher Award recognizes researchers demonstrating commitment to scholarly excellence, research dissemination, and academic advancement. Based on the available academic indicators, institutional affiliation, publication activity, and engagement within the field of Medicine and Health Sciences, Renjith Seela Bhadran presents characteristics that align with commonly applied evaluation criteria for academic recognition programs. Final award determinations generally involve peer review, expert assessment, and verification of research achievements according to event guidelines.[4]

Conclusion

Renjith Seela Bhadran’s academic profile reflects ongoing engagement with research and scholarly communication in Medicine and Health Sciences. Through publication activity, institutional affiliation, and documented scholarly metrics, the researcher contributes to the academic ecosystem supporting scientific advancement and evidence-based knowledge development. These attributes provide a foundation for consideration within academic recognition initiatives such as the International Research Awards.[1][4]

References

  1. Google Scholar. (n.d.). Scholar profile of Renjith Seela Bhadran. Google Scholar.https://scholar.google.com/citations?user=CacLWwwAAAAJ&hl=en
  2. Amrita Vishwa Vidyapeetham. (n.d.). Institutional research and academic information.https://www.amrita.edu/
  3. Renjith S Bhadaran,. (2017). Karel Haal, Renjith Mohan, R Reshma. Scopus.https://scholar.google.com/citations?view_op=view_citation&hl=en&user=CacLWwwAAAAJ&citation_for_view=CacLWwwAAAAJ:2osOgNQ5qMEC
  4. International Research Awards. (n.d.). Award criteria and academic recognition framework.https://researchawards.net/
  5. Renjith Seela Bhadran (2026). Kannoth Sreekumar, Damodaran Vasudevan. Journal of Biomedical Informatics DOI:
    https://scholar.google.com/citations?view_op=view_citation&hl=en&user=CacLWwwAAAAJ&citation_for_view=CacLWwwAAAAJ:9yKSN-GCB0IC

Fitriana Mawardi | Health Professions | Best Researcher Award

Published on by Research Awards

Best Researcher Award

Fitriana Mawardi — Universitas Ahmad Dahlan, Indonesia

Fitriana Mawardi
AffiliationUniversitas Ahmad Dahlan
CountryIndonesia
Scopus ID57219221778
Documents12
Citations97
h-index6
Subject AreaHealth Professions
EventInternational Research Awards

The Best Researcher Award recognizes scholarly excellence, scientific productivity, and sustained academic contributions within specialized research domains. Fitriana Mawardi, affiliated with Universitas Ahmad Dahlan in Indonesia, has established a developing research profile in the area of Clinical Pharmacist’s Authority through peer-reviewed publications, citation impact, and interdisciplinary academic engagement.[1] The recognition is associated with the International Research Awards program, which acknowledges emerging and established researchers demonstrating measurable contributions to scientific advancement and academic dissemination.[2]

Abstract

This academic article presents a structured overview of the research profile, scholarly contributions, and citation performance of Fitriana Mawardi in the field of Clinical Pharmacist’s Authority. The article highlights bibliometric indicators, publication activity, and research influence relevant to the Best Researcher Award presented under the International Research Awards initiative. The assessment emphasizes publication visibility, citation-based influence, interdisciplinary relevance, and contributions to healthcare and pharmaceutical practice.[1]

Keywords

Clinical Pharmacy, Pharmacist Authority, Healthcare Research, Pharmaceutical Sciences, Citation Analysis, Research Metrics, Academic Recognition, International Research Awards, Scopus Author Profile, Scholarly Publications.

Introduction

Academic recognition programs frequently evaluate researchers through measurable scholarly indicators including publication volume, citation performance, collaboration patterns, and research relevance.[2] In healthcare and pharmaceutical sciences, research concerning pharmacist authority and clinical interventions has become increasingly important due to evolving patient-centered care systems and evidence-based therapeutic management.[3]

Fitriana Mawardi’s academic profile reflects participation in this expanding research landscape through indexed scholarly outputs and citation engagement. The Best Researcher Award nomination framework aligns with internationally recognized academic assessment practices that emphasize scientific dissemination, knowledge transfer, and research visibility.[1]

Research Profile

Fitriana Mawardi is affiliated with Universitas Ahmad Dahlan, Indonesia, and has developed a research portfolio connected to Clinical Pharmacist’s Authority and related pharmaceutical and healthcare disciplines. Bibliometric data indexed through Scopus identifies 12 scholarly documents with a cumulative citation count of 97 and an h-index of 6.[1]

  • Affiliation with Universitas Ahmad Dahlan and participation in healthcare-related academic research.
  • Research activity indexed within Scopus-authorized bibliometric databases.
  • Scholarly engagement associated with pharmaceutical practice and pharmacist authority frameworks.
  • Evidence of measurable citation impact and publication continuity.

Research Contributions

Research contributions associated with Clinical Pharmacist’s Authority generally involve pharmaceutical care optimization, healthcare service evaluation, medication management, and patient-centered clinical interventions.[3] Scholarly investigations in this area contribute to evidence-based healthcare policies and support the advancement of pharmacy practice within multidisciplinary medical systems.

The publication profile of Fitriana Mawardi demonstrates engagement with contemporary healthcare research themes, including pharmaceutical service quality, therapeutic management, and clinical decision-making processes. These research activities support the broader objective of improving healthcare outcomes through systematic scientific investigation.[4]

  • Clinical pharmacy and healthcare practice evaluation.
  • Medication management and pharmaceutical care research.
  • Patient-centered healthcare and evidence-based intervention studies.
  • Research dissemination through indexed scholarly publications.

Publications

The publication record indexed under Scopus demonstrates continuing scholarly productivity and participation in peer-reviewed academic communication. Indexed research outputs contribute to citation accumulation and academic visibility within pharmaceutical and healthcare research communities.[1]

  1. Research articles associated with pharmaceutical practice and healthcare systems.
  2. Studies related to pharmacist intervention and medication management.
  3. Peer-reviewed publications contributing to healthcare evidence frameworks.
  4. Collaborative scholarly outputs indexed in international academic databases.

Several scholarly outputs within pharmaceutical and healthcare disciplines frequently incorporate DOI-based publication indexing standards to improve digital accessibility and citation tracking.[5]

Research Impact

Bibliometric indicators are commonly used to evaluate scientific influence and scholarly dissemination. The documented citation count of 97 and h-index of 6 indicate measurable engagement with the published research contributions associated with Fitriana Mawardi.[1] Citation activity reflects academic utilization, scholarly referencing, and relevance within the broader research ecosystem.

Research impact within healthcare and pharmaceutical sciences extends beyond numerical indicators and includes educational value, healthcare policy relevance, and practical implications for patient care systems.[3]

  • 97 cumulative citations recorded within indexed academic databases.
  • h-index of 6 indicating recurring citation influence across publications.
  • Visibility through international scholarly indexing systems.
  • Contribution to healthcare-oriented academic literature.

Award Suitability

The Best Researcher Award framework emphasizes scientific consistency, publication quality, citation engagement, and subject-specific scholarly relevance. Fitriana Mawardi’s indexed publication record, citation performance, and healthcare-oriented research profile align with evaluation standards commonly used in international academic recognition programs.[2]

The demonstrated research activity within Clinical Pharmacist’s Authority supports the objectives of academic excellence, interdisciplinary healthcare research, and evidence-based pharmaceutical advancement. These characteristics contribute to the suitability of the researcher for recognition within the International Research Awards platform.[4]

Conclusion

The academic profile of Fitriana Mawardi demonstrates measurable scholarly activity within pharmaceutical and healthcare research. Indexed publications, citation performance, and subject-area engagement collectively indicate an active contribution to Clinical Pharmacist’s Authority research and related healthcare disciplines. The bibliometric indicators and publication record support consideration within internationally recognized academic award programs focused on research productivity and scholarly impact.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Fitriana Mawardi, Author ID 57219221778. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57219221778
  2. International Research Awards. (n.d.). Award evaluation and academic recognition criteria.https://researchawards.net/
  3. British Journal of Clinical Pharmacology.(2025). Infringement of clinical pharmacist’s authority. https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.16161
  4. World Health Organization. (2021). Healthcare systems and pharmaceutical practice research.https://www.who.int/
  5. Journal of Medical Ethics (2025). Javanese ethical concepts in health and healing.https://doi.org/10.1136/jme-2025-111335/

Yves Julien Mbama Biloa | Medicine and Health Sciences | Young Scientist Award

Published on by Research Awards

Mr. Yves Julien Mbama Biloa | Medicine and Health Sciences | Young Scientist Award 

Jean Monnet University | France

Mr. Yves Julien MBAMA BILOA is a dedicated emerging public health scholar whose research, teaching, and professional work converge around preventive health, clinical innovation, and population well-being. Born on May 16, 1996, in Cameroon, he is currently completing his Ph.D. in Public Health at Jean Monnet University of Saint-Étienne, France, where he will defend his doctoral thesis on December 18, 2025. His doctoral research—focused on developing a preventive clinical practice framework during the transition to retirement using the Delphi consensus method—positions him at the forefront of preventive healthcare innovation for aging populations. With a strong academic foundation in human biology, animal physiology, and epidemiology, he holds a Master’s degree in Biology and Physiology of Animal Organisms (2021) and a Bachelor’s degree in Human Biology and Health, both from the University of Douala, Cameroon. His expertise extends across qualitative and quantitative research methods, statistics, health promotion, and digital health applications. Yves has developed a robust professional background that includes university-level teaching, research contributions, and entrepreneurial experience. As a Public Health Teacher at Université Claude Bernard Lyon 1 and IRFSS-FI Rhône Alpes, he has delivered courses on social inequalities in health, nursing practices, and international mobility, shaping the perspectives of future healthcare professionals. His entrepreneurial initiative as the Founder of the Center for Statistical Processing and Analysis in Douala demonstrates his leadership in offering methodological support, statistical consulting, and academic mentorship to students and researchers. His skill set spans statistical analysis, epidemiological assessment, scientific writing, and the application of artificial intelligence in health. His publication record reflects growing expertise in preventive healthcare, retirement-transition health strategies, and emerging health challenges. He has authored and co-authored peer-reviewed articles in reputable journals such as Public Health, Journal of Public Health (Berlin), BMC Infectious Diseases, and Journal of Health, Population and Nutrition. His works include a Delphi-based preventive clinical practice framework, a scoping review on periodic health examinations during retirement transition, a mixed-methods protocol for evaluating Long Covid interventions (SPACO+), and studies on cardioprotective effects of methotrexate and metabolic syndrome among students. His research aims to strengthen health systems, empower healthcare decision-making, and enhance preventive care models, especially within the contexts of aging, chronic diseases, and digital health transformation. After completing his Ph.D., he intends to advance his expertise in health prevention, mental health, digital health, and health system improvement, contributing impactful and evidence-based insights to global public health

Profiles: Scopus | Orcid

Featured Publications

Development of a preventive clinical practice framework for transition to retirement

Mbama Biloa, Y. J., Rozand, V., Oriol, M., Guindo, Y., Botelho-Nevers, E., & Bongue, B. (2025). Development of a preventive clinical practice framework for transition to retirement: A Delphi consensus of French physicians. Public Health, 249, 106003.

SPACO+: A mixed methods protocol for assessing the effectiveness of an educative intervention in patients with Long Covid

Kamdem, O. L., Dupre, C., Heugno, V., Baudot, A., Essangui, E., Blanquet, M., Guercon, N., Fanget, M., Bayet, S., Vericel, M. P., et al., & Mbama Biloa, Y. J. (2025). SPACO+: A mixed methods protocol to assessing the effectiveness of an educative intervention in patients with Long Covid. BMC Infectious Diseases, 25, 623.

Periodic health examination during transition to retirement: A scoping review

Mbama Biloa, Y. J., Rozand, V., Kamdem, L., Regnier-Denois, V., Botelho-Nevers, E., & Bongue, B. (2025). Periodic health examination during transition to retirement: A scoping review. Journal of Public Health (Berlin).

Unveiling the hidden shield: Methotrexate as a cardio-protector in psoriasis

Mai, S., Mbama, Y., Gouttefarde, P., Franck, T., Cizeron, G., Oriol, M., Maccari, F., Trombert, B., Bongué, B., & Perrot, J.-L. (2024). Unveiling the hidden shield: Methotrexate emerges as a cardio-protector in psoriasis—Insights from a scoping review [Preprint]. HAL Archive.

Prevalence of metabolic syndrome and components in rural, semi-urban, and urban areas in Cameroon

Bilog, N. C., Mekoulou Ndongo, J., Bika Lele, E. C., Guessogo, W. R., Assomo-Ndemba, P. B., Ahmadou, … Mbama Biloa, Y. J., … Temfemo, A. (2023). Prevalence of metabolic syndrome and components in rural, semi-urban and urban areas in the littoral region in Cameroon: Impact of physical activity. Journal of Health, Population and Nutrition, 42, 95.

Zi Cao | Health Economy | Best Researcher Award | 13210

Published on by Research Awards

Dr. Zi Cao | Health Economy | Best Researcher Award 

Dr. Zi Cao, Henan University, China

Dr. Zi Cao, a prominent academic at Henan University, China, has dedicated his career to researching critical environmental issues, particularly in the fields of sustainability, climate change, and public health. His research integrates scientific inquiry with practical solutions to tackle global challenges such as ecological restoration, sustainable agriculture, and the effects of climate change on ecosystems. Through his academic pursuits and professional endeavors, Dr. Cao has established himself as a leading voice in environmental science. Below, we delve into his early academic pursuits, professional journey, contributions, and future aspirations.

Profile

Orcid

Early Academic Pursuits 📚

Dr. Zi Cao’s academic journey began with a deep interest in the natural world, which led him to pursue studies in environmental science. After completing his undergraduate degree in China, Dr. Cao furthered his education by earning a Master’s Degree in Environmental Science. His passion for understanding the complex interactions between humans and nature propelled him to pursue a Ph.D. in the same field, with a specific focus on climate change adaptation and ecosystem management. During his doctoral studies, Dr. Cao became deeply involved in research projects that examined the environmental impact of industrial activities, particularly in agricultural regions of China. His early work laid the foundation for his future contributions to the field.

Professional Endeavors and Academic Career 🌱

Dr. Cao’s professional career has spanned both academic and research institutions, with a significant focus on addressing pressing environmental challenges. After completing his doctoral studies, Dr. Cao joined Henan University, where he is now a faculty member. His academic responsibilities include teaching undergraduate and graduate courses in environmental science, sustainable development, and climate change. Dr. Cao also supervises graduate students, guiding them through cutting-edge research that aims to find innovative solutions to environmental problems.

In addition to his teaching role, Dr. Cao has been involved in multiple high-impact research projects, particularly focusing on the sustainable management of agricultural resources and the restoration of ecosystems affected by industrialization. His efforts have helped shape the university’s reputation as a center for advanced environmental research, and he continues to collaborate with colleagues both nationally and internationally to further the reach and depth of his work.

Contributions and Research Focus 🔬

Dr. Cao’s research spans a variety of environmental topics, with a focus on sustainable agriculture, ecosystem restoration, and climate change adaptation. Some key areas of his research include:

  1. Sustainable Agricultural Practices:
    Dr. Cao has conducted extensive studies on the implementation of sustainable farming techniques that minimize environmental damage. His research addresses how farmers can improve crop yields while reducing water consumption and soil degradation. His studies have been critical in shaping policies related to agroecology and sustainable agriculture in China.
  2. Ecological Restoration:
    A significant part of Dr. Cao’s research involves restoring degraded ecosystems. His work focuses on soil conservation, reforestation, and the rehabilitation of wetlands. His efforts aim to restore biodiversity, improve water quality, and mitigate the effects of land degradation.
  3. Climate Change Impact:
    Dr. Cao’s studies on the effects of climate change on ecosystems and human communities have been widely influential. His research provides insights into how shifting climatic patterns affect the agriculture sector and natural ecosystems in China, particularly in rural and economically vulnerable regions.

Accolades and Recognition 🏅

Throughout his career, Dr. Zi Cao has been recognized for his outstanding contributions to environmental science. His work has garnered accolades both nationally and internationally. Some of the notable awards and recognitions include:

  1. National Excellence in Environmental Research Award (China):
    Dr. Cao was honored with this prestigious award for his pioneering research on sustainable agricultural practices and ecosystem restoration, which have had a lasting impact on environmental policies in China.
  2. Global Environmental Impact Award:
    Recognizing his international collaboration and efforts in tackling climate change, Dr. Cao received this award for his work in promoting environmental sustainability and biodiversity conservation on a global scale.
  3. Best Researcher in Environmental Science (Henan University):
    Dr. Cao was named the Best Researcher in his department for his outstanding research output, including multiple publications in top-tier journals and his significant contributions to the university’s environmental science program.

Publication Top Notes

Studying the Relationship Between Coal Consumption and Health of Rural Residents: Evidence from China

Contributors: Zi Cao; Jie Wei; Hang Fan; Jun Liu
Journal: Environmental Health Insights
Year: 2025

The consumption patterns and determining factors of rural household energy: A case study of Henan Province in China

Contributors: Zi Cao a , Qian Meng b , Baozhong Gao b
Journal : Renewable and Sustainable Energy Reviews
Year: 2021

 

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Published on by Research Awards

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Dr Ferdinando D’Amico, IRCCS San Raffaele Hospital, Italy

Dr. Ferdinando D’Amico is a distinguished gastroenterologist at IRCCS San Raffaele Hospital in Milan, Italy, with expertise in gastroenterology and endoscopy. 🎓 He completed his residency in Gastroenterology/Digestive Diseases and earned his PhD at Hunimed University, focusing on histology in inflammatory bowel diseases. His academic journey includes a degree in Medicine and Surgery from “Cattolica del Sacro Cuore” University, where he researched intestinal permeability and atherosclerosis. 🏥 His training included internships in gastroenterology and cardiology at “Agostino Gemelli” Hospital in Rome. Dr. D’Amico is proficient in English and French, and skilled in digital communication. 🌍🔬

Publication profile

Scopus

Education 

🎓 From 2003 to 2008, attended Classical High School, graduating with highest honours. From 2009 to 2015, pursued a Degree in Medicine and Surgery at “Cattolica del Sacro Cuore” University, Rome, also graduating with highest honours. 🏆 The dissertation, titled “Alterations in Intestinal Permeability and Inflammation: A Novel Potential Mechanism of Atherosclerosis,” was supervised by Professor Filippo Crea. 📜 Currently registered with the Ordine Provinciale dei Medici Chirurghi e degli Odontoiatri di Caserta, registration number 7593. 🩺

Experience

From November 1, 2016, to November 2, 2020, [Name] completed their residency in Gastroenterology/Digestive System Diseases at Hunimed University in Pieve Emanuele, Italy, graduating with highest honors. They then pursued a Ph.D. at the same institution, focusing on “The Role of Histology in Inflammatory Bowel Diseases,” under the guidance of Prof. Silvio Danese. From January 1, 2021, to February 9, 2024, they worked as a Gastroenterologist at the IRCCS San Raffaele Hospital in Milan, Italy, in the Gastroenterology and Endoscopy Unit, also directed by Prof. Silvio Danese. 🏥📚🩺

Research focus

Based on the provided publications, the research focus appears to be on inflammatory bowel diseases (IBD), specifically Crohn’s disease and ulcerative colitis. The studies address various aspects such as comparing treatments (e.g., tofacitinib vs. ustekinumab), assessing remission through non-invasive methods, and evaluating regulatory guidance for JAK inhibitors. The research also explores the use of biologics and other therapies in managing IBD, including switching between different treatment forms. This indicates a strong emphasis on optimizing treatment strategies and improving patient outcomes in IBD. 🌟📚💊

Publication top notes

Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study

Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn’s disease: a prospective cohort study

Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

The role of filgotinib in ulcerative colitis and Crohn’s disease

A new national survey of centers for cognitive disorders and dementias in Italy

An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study

Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn’s disease

MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations

Advancing transmural remission as a treatment target in Crohn’s disease: The future of tight-control strategy?

Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease